Related Experiment Video
Updated: Apr 17, 2026
04:01
Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
1.8K
Recurrence of papillary thyroid cancer after optimized surgery
1Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Gland Surgery
|February 26, 2015
Summary
Papillary thyroid cancer (PTC) recurrence is shifting focus from survival to early detection. Optimized surgery and advances like ultrasound enable detection of subclinical disease, aiming to reduce recurrence rates.
Area of Science:
- Endocrinology
- Surgical Oncology
- Diagnostic Imaging
Background:
- Papillary thyroid cancer (PTC) presentation has evolved, with smaller tumors (papillary thyroid microcarcinomas) often detected incidentally.
- PTC is highly curable (85%), with a shift in focus towards managing recurrence rather than solely survival.
- Technological advances like high-resolution ultrasound (US), recombinant TSH, and sensitive thyroglobulin (Tg) assays facilitate early detection of subclinical disease recurrence.
Purpose of the Study:
- To analyze the evolving landscape of papillary thyroid cancer (PTC) management over the last 15 years.
- To discuss optimized surgical approaches for PTC in light of changing disease characteristics and detection methods.
- To detail the types, implications, and management strategies for PTC recurrence.
Main Methods:
- Review of recent trends in PTC presentation and diagnosis, including the impact of advanced imaging.
- Analysis of surgical strategies, including extent of thyroid resection and lymphadenectomy controversies.
- Examination of postoperative surveillance techniques and their role in detecting subclinical recurrence.
Main Results:
- Smaller PTCs and microcarcinomas are increasingly detected, often cured by conservative surgery with low recurrence rates.
- High-resolution ultrasound and sensitive biomarkers enable detection of subclinical disease, influencing treatment decisions like radioactive iodine ablation.
- Controversies exist regarding prophylactic central neck lymphadenectomy when intraoperative assessment is uncertain.
Conclusions:
- Optimized surgical approaches, including bilateral thyroid resection and appropriate lymphadenectomy, can achieve low recurrence rates (approx. 5%).
- Understanding the different forms of recurrence (lymph node metastasis, local, distant) is crucial for effective management.
- The integration of advanced imaging and sensitive diagnostics allows for proactive management of PTC recurrence.
